Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 407Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

PATIROMER SORBITEX CALCIUM

Brand Name : VELTASSA

Patent Number : 2806465

Filing Date : 2005-03-30

Strength per Unit : 8.4g

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-03-30

Date Granted : 2016-05-24

blank

02

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

PATIROMER SORBITEX CALCIUM

Brand Name : VELTASSA

Patent Number : 2558029

Filing Date : 2005-03-30

Strength per Unit : 8.4g

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-03-30

Date Granted : 2013-05-07

blank

03

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

PATIROMER SORBITEX CALCIUM

Brand Name : VELTASSA

Patent Number : 2558029

Filing Date : 2005-03-30

Strength per Unit : 16.8g

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-03-30

Date Granted : 2013-05-07

blank

04

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

PATIROMER SORBITEX CALCIUM

Brand Name : VELTASSA

Patent Number : 2558029

Filing Date : 2005-03-30

Strength per Unit : 25.2g

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-03-30

Date Granted : 2013-05-07

blank

05

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

PATIROMER SORBITEX CALCIUM

Brand Name : VELTASSA

Patent Number : 2806465

Filing Date : 2005-03-30

Strength per Unit : 25.2g

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-03-30

Date Granted : 2016-05-24

blank

06

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

PATIROMER SORBITEX CALCIUM

Brand Name : VELTASSA

Patent Number : 2886788

Filing Date : 2013-10-08

Strength per Unit : 25.2g

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-10-08

Date Granted : 2022-04-19

blank

07

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

PATIROMER SORBITEX CALCIUM

Brand Name : VELTASSA

Patent Number : 2886788

Filing Date : 2013-10-08

Strength per Unit : 8.4g

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-10-08

Date Granted : 2022-04-19

blank

08

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

PATIROMER SORBITEX CALCIUM

Brand Name : VELTASSA

Patent Number : 2806465

Filing Date : 2005-03-30

Strength per Unit : 16.8g

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-03-30

Date Granted : 2016-05-24

blank

09

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

PATIROMER SORBITEX CALCIUM

Brand Name : VELTASSA

Patent Number : 2886788

Filing Date : 2013-10-08

Strength per Unit : 16.8g

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-10-08

Date Granted : 2022-04-19

blank